+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotype-genotype relations in growth hormone insensitivity



Phenotype-genotype relations in growth hormone insensitivity



Archives de Pediatrie 5(Suppl. 4): 364s



Growth hormone (GH) insensitivity is associated with several different mutations of the GH receptor gene and a recently described new genetic disorder of the IFGI gene. The phenotype and biochemical characteristics were studied in 82 patients with growth hormone insensitivity, from 23 different countries, with a mean age of 8.25 years. Mean height SDS was -6.09. SDS of the IGF binding protein -3 (IGF BP3) was 7.99. Twenty three per cent of the patients were GH binding protein (GHBP) positive (> 10%). Mean height SDS score was -6.5 in the GHBP negative patients and -4.9 in the GHBP positive patients (p < 0.001). Fifteen different mutations of the GH receptor gene were identified in 27 patients. There were no relationships between the type of mutation or the involved GH receptor gene exon and height or IGFBP-3 SDS. The new phenotype due to a partial deletion of the IGFI gene was described in a 15-year-old boy who presented with a severe intrauterine growth retardation, a very poor postnatal statural growth, a neurosensorial deafness and a mild mental retardation. He had elevated GH levels, normal levels of IGFBP3, undetectable levels of IGFI, and showed no response to GH treatment. A partial deletion concerning the exons 4 and 5 of the IGFI gene was found. Thus, GH insensitivity is associated with large variations in the clinical and biochemical phenotypes.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973732

Download citation: RISBibTeXText

PMID: 9853085


Related references

Phenotype: genotype relationships in growth hormone insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 82(11): 3529-3535, 1997

Relationship between phenotype and genotype in growth hormone insensitivity syndrome. Acta Paediatrica . Supplement 88(428): 158, 1999

Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paediatrica . Supplement 399: 117-124, 1994

Treatment of growth hormone insensitivity syndrome with insulin-like growth factor I Relationship between growth response and severity of phenotype. Acta Paediatrica Suppl. (428): 193, 1999

Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. Acta Paediatrica Suppl. (428): 182-184, 1999

Phenotype heterogeneity in inherited growth hormone insensitivity. Archives de Pediatrie 5(Suppl. 4): 364S-370S, 1998

Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes. Hormone Research 51(3): 128-134, 1999

Atypical facial phenotype in growth hormone insensitivity syndrome patients Relationship of facial phenotype to clinical and biological variables. Hormone Research 51(Suppl. 2): 34, 1999

Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. GHIS Collaborative Group. Acta Paediatrica . Supplement 88(428): 182-184, 1999

Growth response to rhIGF-I 80 mug/kg bid in children with growth hormone insensitivity syndrome Relationship to severity of clinical phenotype. Hormone Research (Basel) 50(Suppl. 3): 11, 1998

Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype. Clinical Endocrinology 51(6): 787-792, 1999

Growth hormone insensitivity: physiologic and genetic basis, phenotype, and treatment. Journal of Pediatrics 135(3): 280-289, 1999

Clinical spectrum of the syndrome of growth hormone insensitivity. Advisory Committee on Growth Hormone Insensitivity. Acta Paediatrica Scandinavica. Supplement 377: 87, 1991

An atypical growth hormone insensitivity phenotype is produced by a novel intronic point mutation in the human GH receptor gene. Hormone Research 53(Suppl 2): 8, 2000

Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paediatrica . Suppl. 82 Suppl 391: 15-19, 1993